Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients

AIMS: A close association has been demonstrated between increased cardiovascular risk and high asymmetric dimethylarginine (ADMA) levels in type 2 diabetes mellitus (DM) patients. We planned to measure serum ADMA levels in type 2 DM patients using vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cakirca, Mustafa, Karatoprak, Cumali, Zorlu, Mehmet, Kiskac, Muharrem, Kanat, Mustafa, Cikrikcioglu, Mehmet Ali, Soysal, Pinar, Hursitoglu, Mehmet, Camli, Ahmet Adil, Erkoc, Reha, Abdul-Ghani, Muhammad
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3931658/
https://ncbi.nlm.nih.gov/pubmed/24627624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S52545
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars